Line 174: | Line 174: | ||
<br><br> The GDC (GlyDH-DAK-ceaS2) pathway was designed in order to improve the ability of chassis cells | <br><br> The GDC (GlyDH-DAK-ceaS2) pathway was designed in order to improve the ability of chassis cells | ||
to convert glycerol to DHAP and finally synthesize acrylic acid. We also added NOX (NADH dehydrogenase) | to convert glycerol to DHAP and finally synthesize acrylic acid. We also added NOX (NADH dehydrogenase) | ||
− | and CAT (Catalase) to this pathway to provide the required reducing power for | + | and CAT (Catalase) to this pathway to provide the required reducing power for GlyDH by two layers |
of substrate circulation. Ultimately, GNCDC (GlyDH-NOX-CAT-DAK-ceaS2) is our desired new biosynthetic | of substrate circulation. Ultimately, GNCDC (GlyDH-NOX-CAT-DAK-ceaS2) is our desired new biosynthetic | ||
pathway of acrylic acid. | pathway of acrylic acid. |
Revision as of 14:05, 1 November 2017